Evidence map›Paper›PMID 35276209›Full record

ArticleGastrointestinal endoscopy2022

Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry.

Joseph C Anderson, William Hisey, Todd A Mackenzie, Christina M Robinson, Amitabh Srivastava, Reinier G S Meester, Lynn F Butterly

Registry-linked trialAbstract read
In one paragraph

Article in Gastrointestinal endoscopy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07127471 (A Multicenter Prospective Randomized Controlled Trial of Linked-Color Imaging for Detection of Clinically Significant Serrated Lesions in Computer-Aided Water Exchange Colonoscopy), which is not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07127471 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Multicenter Prospective Randomized Controlled Trial of Linked-Color Imaging for Detection of Clinically Significant Serrated Lesions in Computer-Aided Water Exchange Colonoscopy

TypeinterventionalSponsorEvergreen General Hospital, TaiwanRan2025 to 2027Enrolled1,090ConditionsSessile Colonic Polyp, Serrated Lesion, Sessile Serrated Lesion, Colon AdenomasArmsWater exchange with AI-assisted detection, Water exchange with AI-assisted detection and LCI
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Quality indicators for colonoscopy.Gastrointestinal endoscopy · 2024
    Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mixed lesions in premalignant colorectal polyps.Journal of clinical biochemistry and nutrition · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Joseph C AndersonGeisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA; White River Junction VAMC, White River Junction, Vermont, USA.
William HiseyDepartment of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; New Hampshire Colonoscopy Registry, Lebanon, New Hampshire, USA.
Todd A MackenzieGeisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Christina M RobinsonDepartment of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; New Hampshire Colonoscopy Registry, Lebanon, New Hampshire, USA.
Amitabh SrivastavaMemorial Sloane Kettering Cancer Center, New York, New York, USA.
Reinier G S MeesterErasmus Medical Center, Erasmus, Netherlands.
Lynn F ButterlyGeisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA; Department of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; New Hampshire Colonoscopy Registry, Lebanon, New Hampshire, USA.

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
NH COMPREHENSIVE CANCER CONTROL PROGRAM & CANCER REGISTRYU58DP003930 · DP · NH STATE DEPT/HLTH STATISTICS/DATA MGMT · PI MONTERO, JOSE THEIR · 2012 to 2014
$7.0M
Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modelingR01CA243449 · NCI · DARTMOUTH-HITCHCOCK CLINIC · PI AMOS, CHRISTOPHER I., BUTTERLY, LYNN F · 2020 to 2024
$3.0M
NCCDPHP CDC HHS U58 DP003930NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA243449
6 · The paper itself

Abstract

BACKGROUND AND

aimsHigher adenoma detection rates reduce the risk of postcolonoscopy colorectal cancer (PCCRC). Clinically significant serrated polyps (CSSPs; defined as any sessile serrated polyp, traditional serrated adenoma, large [≥1 cm] or proximal hyperplastic polyp >5 mm) also lead to PCCRC, but there are no data on associated CSSP detection rates (CSSDRs). We used data from the New Hampshire Colonoscopy Registry (NHCR) to investigate the association between PCCRC risk and endoscopist CSSDR.

methodsWe included NHCR patients with 1 or more follow-up events: either a colonoscopy or a colorectal cancer (CRC) diagnosis identified through linkage with the New Hampshire State Cancer Registry. We defined our outcome, PCCRC, in 3 time periods: CRC diagnosed 6 to 36 months, 6 to 60 months, or all examinations (6 months or longer) after an index examination. We excluded patients with CRC diagnosed at or within 6 months of the index examination, with incomplete examinations, or with inflammatory bowel disease. The exposure variable was endoscopist CSSDR at the index colonoscopy. Cox regression was used to model the hazard of PCCRC on CSSDR controlling for age, sex, index findings, year of examination, personal history of colorectal neoplasia, and having more than 1 surveillance examination.

resultsOne hundred twenty-eight patients with CRC diagnosed at least 6 months after their index examination were included. Our cohort included 142 endoscopists (92 gastroenterologists). We observed that the risk for PCCRC 6 months or longer after the index examination was significantly lower for examinations performed by endoscopists with CSSDRs of 3% to <9% (hazard ratio [HR], .57; 95% confidence interval [CI], .39-.83) or 9% or higher (HR, .39; 95% CI, .20-.78) relative to those with CSSDRs under 3%.

conclusionsOur study is the first to demonstrate a lower PCCRC risk after examinations performed by endoscopists with higher CSSDRs. Both CSSDRs of 9% and 3% to <9% had statistically lower risk of PCCRC than CSSDRs of <3%. These data validate CSSDR as a clinically relevant quality measure for endoscopists.

Indexed as

AdenomaColonic PolypsColorectal NeoplasmsPolypsColonoscopyHumansNew HampshireRegistries

Identifiers

PMID35276209
PMCPMC9296608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.